Patients with acromegaly require fortnightly or monthly injections of somatostatin analogs during clinic visits. The introduction of lanreotide, in the form of Somatuline Autogel ® (SCRAS ...

The authors conclude that the time interval between injections of lanreotide can be prolonged to 6 weeks in patients whose acromegaly is well-controlled on 4-weekly injections, without loss of ...

Somatuline is a best-in-class somatostatin analog for the treatment of neuroendocrine tumors and acromegaly, a growth hormone disorder. Somatuline’s strong cash flows have allowed Ipsen to ...